Literature DB >> 17256034

Ethical and practical issues with opioids in life-limiting illness.

Robert L Fine1.   

Abstract

Effective pain relief, especially at the end of life, is a primary ethical obligation based upon the principles of beneficence, nonmaleficence, patient autonomy, and particularly the concept of double effect. The pragmatic foundation of pain management begins with a complete assessment, which incorporates "WILDA" (words, intensity, location, duration, aggravating/alleviating factors) and considers the components of total pain: physical, emotional, social, and spiritual pain. Opioids are the pharmacologic sine qua non of pain management in life-limiting illness and should be prescribed based on the severity of pain, considering the functional and psychological significance of that severity. Numerous misunderstandings present a barrier to effective pain management. These misconceptions include the idea that opioids are highly addictive, that dependence or tolerance are forms of addiction, that respiratory depression is common with opioids, that opioids have a narrow therapeutic range, and that opioids are ineffective by mouth and cause too much nausea. In reality, opioids are the safest and most effective pain medicine for most moderate to severe pain in most patients. Aspects of basic opioid pharmacology, such as dosage, route of administration, rotation of drugs, and the avoidance of toxicity and complications, should be considered when initiating and maintaining therapy. Failure to pay attention to the basic rules can lead to errors in opioid management.

Entities:  

Year:  2007        PMID: 17256034      PMCID: PMC1769525          DOI: 10.1080/08998280.2007.11928223

Source DB:  PubMed          Journal:  Proc (Bayl Univ Med Cent)        ISSN: 0899-8280


  8 in total

1.  A long-term survey of morphine in cancer pain patients.

Authors:  S A Schug; D Zech; S Grond; H Jung; T Meuser; B Stobbe
Journal:  J Pain Symptom Manage       Date:  1992-07       Impact factor: 3.612

2.  Long-term oral opioid therapy in patients with chronic nonmalignant pain.

Authors:  M Zenz; M Strumpf; M Tryba
Journal:  J Pain Symptom Manage       Date:  1992-02       Impact factor: 3.612

3.  'Total pain', disciplinary power and the body in the work of Cicely Saunders, 1958-1967.

Authors:  D Clark
Journal:  Soc Sci Med       Date:  1999-09       Impact factor: 4.634

Review 4.  A systematic review of the use of opioids in the management of dyspnoea.

Authors:  A-L Jennings; A N Davies; J P T Higgins; J S R Gibbs; K E Broadley
Journal:  Thorax       Date:  2002-11       Impact factor: 9.139

5.  Patterns of narcotic drug use in a cancer pain clinic.

Authors:  R M Kanner; K M Foley
Journal:  Ann N Y Acad Sci       Date:  1981       Impact factor: 5.691

6.  Subcutaneous morphine for dyspnea in cancer patients.

Authors:  E Bruera; T MacEachern; C Ripamonti; J Hanson
Journal:  Ann Intern Med       Date:  1993-11-01       Impact factor: 25.391

7.  Addiction rare in patients treated with narcotics.

Authors:  J Porter; H Jick
Journal:  N Engl J Med       Date:  1980-01-10       Impact factor: 91.245

8.  Management of pain during debridement: a survey of U.S. burn units.

Authors:  Samuel Perry; George Heidrich
Journal:  Pain       Date:  1982-07       Impact factor: 6.961

  8 in total
  2 in total

1.  Symptom trends in the last year of life from 1998 to 2010: a cohort study.

Authors:  Adam E Singer; Daniella Meeker; Joan M Teno; Joanne Lynn; June R Lunney; Karl A Lorenz
Journal:  Ann Intern Med       Date:  2015-02-03       Impact factor: 25.391

2.  Indicators of drug-seeking aberrant behaviours: the feasibility of use in observational post-marketing cohort studies for risk management.

Authors:  Deborah Layton; Vicki Osborne; Mohammad Al-Shukri; Saad A W Shakir
Journal:  Drug Saf       Date:  2014-08       Impact factor: 5.606

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.